Skip to content
★ Sign in to follow
HR

Harald Reinhart

Directeur Médical
Total declarations
65
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (34 ops.)
€13.8M

Latest filing published 27 Jun 2024 for Zai Lab Ltd.

Insider track record

Disclosed buys
0
Disclosed sells
34

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Harald Reinhart: trading record in brief

All filings by Harald Reinhart on record concern Zai Lab Ltd, in the capacity of senior executive. Over a trading history stretching from 20 April 2021 to 26 June 2024, the count stands at 65 filings.

Sales make up the whole of the open-market record (34 sales, €13.8M). Outside the open market, there are 7 share grants and 24 option exercises. So far in 2024, the count stands at no purchases and 5 sales.

The record was last updated on 27 June 2024 with an open-market sale (€125k) in Zai Lab Ltd. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Harald Reinhart

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total
  • ◇
    See RemarksExecutivesZai Lab Ltd
    0SEC
    18,250 sharesAmerican Depositary SharesSEC:0000905148-24-001804:0
  • ◇
    See RemarksExecutivesZai Lab Ltd
    83,793 USD0SEC
    5,270 shares@ US$15.902.9% of flowAmerican Depositary SharesSEC:0000905148-24-001113:0
  • ◇
    See RemarksExecutivesZai Lab Ltd
    55,811 USD0SEC
    3,338 shares@ US$16.722.0% of flowAmerican Depositary SharesSEC:0000905148-24-001094:0
  • ◇
    See RemarksExecutivesZai Lab Ltd
    0SEC
    17,548 sharesAmerican Depositary SharesSEC:0000905148-24-000061:0
  • ◇
    See RemarksExecutivesZai Lab Ltd
    461,725 USD2SEC
    18,250 shares@ US$25.3015.8% of flowAmerican Depositary SharesSEC:0000950170-23-029861:0
  • ◇
    See RemarksExecutivesZai Lab Ltd
    33,593 USD0SEC
    1,010 shares@ US$33.261.2% of flowAmerican Depositary SharesSEC:0000899243-23-010212:0
  • ◇
    See RemarksExecutivesZai Lab Ltd
    34,440 USD0SEC
    11,480 shares@ US$3.001.2% of flowAmerican Depositary SharesSEC:0000899243-23-007331:0
  • ◆
    See RemarksExecutivesZai Lab Ltd
    181,222 USD1SEC
    5,903 shares@ US$30.706.4% of flowAmerican Depositary SharesSEC:0000899243-23-000205:0
  • ◆
    See RemarksExecutivesZai Lab Ltd
    11,186 USD0SEC
    246 shares@ US$45.470.4% of flowAmerican Depositary SharesSEC:0000899243-22-036308:0
  • ◇
    See RemarksExecutivesZai Lab Ltd
    0SEC
    1,010 shares0American Depositary SharesSEC:0000899243-22-013699:0
  • ◆
    See RemarksExecutivesZai Lab Ltd
    408,665 USD4SEC
    5,903 shares@ US$69.2320.9% of flowOrdinary SharesSEC:0001567619-21-022691:0
  • ◆
    See remarksExecutivesZai Lab Ltd
    0SEC
    30,000 shares0Ordinary SharesSEC:0000899243-21-049736:0
  • ◇
    Chief Medical OfficerExecutivesZai Lab Ltd
    30,000 USD11SEC
    10,000 shares@ US$3.001.5% of flowOrdinary SharesSEC:0001567619-21-016964:0
  • ◇
    Chief Medical OfficerExecutivesZai Lab Ltd
    30,000 USD11SEC
    10,000 shares@ US$3.001.5% of flowOrdinary SharesSEC:0001567619-21-016870:0
  • ◇
    Chief Medical OfficerExecutivesZai Lab Ltd
    143,920 USD12SEC
    8,000 shares@ US$17.997.1% of flowOrdinary SharesSEC:0001567619-21-016336:0
  • ◇
    Chief Medical OfficerExecutivesZai Lab Ltd
    144,000 USD12SEC
    8,000 shares@ US$18.007.1% of flowOrdinary SharesSEC:0001567619-21-013527:0
  • ◇
    Chief Medical OfficerExecutivesZai Lab Ltd
    167,200 USD12SEC
    8,000 shares@ US$20.908.1% of flowOrdinary SharesSEC:0001567619-21-012383:0
  • ◇
    Chief Medical OfficerExecutivesZai Lab Ltd
    167,200 USD12SEC
    8,000 shares@ US$20.907.9% of flowOrdinary SharesSEC:0001567619-21-011217:0

18 of 18 declarations